Analyst Ratings for Seattle Genetics (SGEN) [Buys]
SGEN Rating Summary
SGEN Price Target Summary
- Highest: $37.00 (Goldman Sachs)
- Lowest: $10.00 (Citadel Securities)
- Average: $20.14
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$20.14 (-45.1%)
Avg. $ Target:
$20.14 (-45.1%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/13/2012 | Credit Suisse | New Coverage | Outperform (N/A) |
28.00 (N/A) |
23.45 | 36.70 | 56.5% | Details |
| 7/5/2012 | ThinkEquity | New Coverage | Buy (N/A) |
30.00 (N/A) |
25.83 | 36.70 | 42.08% | Details |
| 5/2/2011 | BofA/Merrill Lynch | New Coverage | Buy (N/A) |
N/A (N/A) |
16.45 | 36.70 | 123.1% | Details |
| 2/17/2011 | Jefferies » Updated 10/12/2011 |
New Coverage | Buy (N/A) |
25.00 (N/A) |
15.01 | 36.70 | 144.5% | Details |
| 11/3/2010 | Leerink Swann » Updated 5/9/2012 |
Upgrade | Outperform (N/A) |
21.00 (N/A) |
14.14 | 36.70 | 159.55% | Details |
